閉場中RVOL 0.0xDV $3,15220日平均DV $727,502?
52W high -79.9%52W low +456.0%Market cap $179,582Avg volume 3.8M
Company Overview
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2026 Q2 | -22.80 | $0 | -$4M |
| 2026 Q1 | -79.50 | $0 | -$4M |
| 2025 Q4 | -119.40 | $0 | -$4M |
| 2025 Q3 | -139.20 | $0 | -$5M |
| 2025 Q2 | -288.60 | $0 | -$4M |
| 2025 Q1 | -1206.00 | $0 | -$3M |
| 2024 Q4 |
Beta access -> Sign in with an invite code